Tags: PharmatrophiX

blog

Clinical Trials Inspiring Hope

Since 1998, the ADDF has invested over $100 million in the best ideas to cure Alzheimer's. We are seeing the impact of our efforts, with many promising drugs in clinical trials on the way.

blog

Closing in on a Cure: Dr. Frank Longo and C-31

We have supported over 20% of all Alzheimer's treatments currently in clinical trials. One of the most promising is C-31, developed by Frank Longo, MD, PhD.

announcements

$1.5 Million in New Grant Funding for Promising Treatments

The Alzheimer’s Drug Discovery Foundation awarded three new grants in September and October totaling nearly $1.5 million. 

blog

Alzheimer’s Drug Featured in Time Was Made Possible by the ADDF

Grantee Dr. Frank Longo's promising new drug to treat Alzheimer's is on the cover of Time magazine.

announcements

Five New Research Grants Support Clinical and Early-Stage Programs

Funded Researchers are pursuing diverse targets to treat Alzheimer's disease.

announcements

Dr. Frank Longo Wins Inaugural Melvin R. Goodes Prize

Dr. Longo's pioneering approach may soon lead to new disease modifying drugs.